NCT01340560

Brief Summary

Objective To evaluate the effect of local injury to the endometrium for implantation, pregnancy and live birth rates in ICSI -ET cycles with recurrent implantation failure. Design Randomized controlled clinical study. Setting A clinical will assist reproductive center of Selcuk University Meram Medical Faculty Hospital in the Konya, Turkey. Population A group of 100 women, who failed to conceive during one or more cycles of IVF and embryo transfer (ET), will treat with a long protocol for controlled ovarian hyperstimulation. Methods The IVF treatment and ET will precede by repeated endometrial biopsies, in a randomly selected 50 of a total of 100 women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2011

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 22, 2011

Completed
Last Updated

April 22, 2011

Status Verified

April 1, 2011

Enrollment Period

4 months

First QC Date

April 13, 2011

Last Update Submit

April 20, 2011

Conditions

Keywords

Endometrium, local injury, implantation, pregnancy, in vitro fertilization

Outcome Measures

Primary Outcomes (3)

  • Implantation ratio

    Implantation ratios were 30.88% in Group 1 and 34.67% in Group 2 (p =0.13). So there wasn't any significant difference for implantation ratios between two groups, but implantation ratio of 34.67% in Group 2 was evaluated as clinically significant

    Six months

  • Clinical pregnancy ratio

    Cardiac activity on USG for clinical pregnancy were determined in seventeen women of the control group (34%) and 30 women of the study group (60%). The clinical pregnancy rate was significiantly higher in the study group with compared to control group (p=0.009)

    six months

  • Live birth ratio

    Twenty two of the 30 pregnancies in the study group ended in the delivery of 27 healthy babies. This stituation represents a rate of live births in the study group that was significiantly higher than control group (44% and 24%) (p= 0.03)

    six months

Secondary Outcomes (3)

  • Implantation ratio

    six months

  • Clinical pregnancy ratio

    six months

  • Live birth ratio

    six months

Interventions

Endometrial biopsy was performed with biopsy catheter

Eligibility Criteria

Age25 Years - 36 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • women who applied to our clinic due to infertility and who undergone one or more failed fresh IVF cycles previously has been included in our study for ICSI-ET (intracytoplasmic sperm injection-embryo transfer).

You may not qualify if:

  • women with factors as hydrosalpenx, trombophilia, submucous myoma and found to have a negative impact on implantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IVF Unit, Department of Obstetrics and Gynecology, Selcuk University Meram Medical Faculty

Konya, 04220, Turkey (Türkiye)

Location

Related Publications (1)

  • Lensen SF, Armstrong S, Gibreel A, Nastri CO, Raine-Fenning N, Martins WP. Endometrial injury in women undergoing in vitro fertilisation (IVF). Cochrane Database Syst Rev. 2021 Jun 10;6(6):CD009517. doi: 10.1002/14651858.CD009517.pub4.

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 13, 2011

First Posted

April 22, 2011

Study Start

September 1, 2010

Primary Completion

January 1, 2011

Study Completion

February 1, 2011

Last Updated

April 22, 2011

Record last verified: 2011-04

Locations